Search

everythinglearnresearchcommunity

for

Search:↓

Topical corticosteroids may be a safe and effective treatment for severe alopecia areata in children.

Janus kinase inhibitors are effective and generally safe for treating hair loss in adults with alopecia areata.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

Baricitinib is a new, effective treatment for advanced alopecia areata but is costly and has risks.

Seborrheic dermatitis may contribute to the development of central centrifugal cicatricial alopecia.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

Some skin conditions may increase the risk of heart disease, but are not yet included in cardiovascular prevention guidelines.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

Ripretinib is effective and safe for treating advanced GIST in Chinese patients, particularly for non-gastric GISTs.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Dupilumab can help regrow hair and improve skin conditions in patients with severe atopic dermatitis and alopecia areata.

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.

Alopecia areata severely impacts quality of life, mental health, and work productivity.

Doctors in the Middle East need better treatments and more knowledge about new therapies for hair loss condition Alopecia Areata.

Eating fewer calories may slow aging and removing old cells can increase lifespan in mice.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

Continued baricitinib treatment leads to significant scalp hair regrowth in severe alopecia areata patients.

The study helps doctors use patient images to understand and apply SALT scores for treating severe alopecia areata.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Baricitinib helps patients with severe alopecia areata regrow hair.

Baricitinib helps with severe hair loss, negative-pressure therapy lowers hernia recurrence, tranexamic acid reduces bleeding, robot-assisted breast surgery may improve outcomes, and acellular dermal matrix could decrease breast reconstruction complications.

Immune cells in Hidradenitis suppurativa become more inflammatory and may be important for treatment targets.

Dupilumab helped a 4-year-old grow hair back after another treatment failed.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

Experts recommend a team-based approach to treat patients with long-lasting COVID-19 symptoms and emphasize the need for ongoing research.